Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus in Adults With Plaque Psoriasis
NCT03343639 is registered in ClinicalTrials.gov with Vyne Therapeutics Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus in Adults With Plaque Psoriasis
- Lead sponsor
- Vyne Therapeutics Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 1, 2017
- Completion date
- November 12, 2018
- Enrollment
- 204 (actual)
- Sites
- 39
Conditions
As the registry lists them; a condition with its own page is linked.